Daniela Ungureanu

9PUBLICATIONS
11CO-AUTHORS
Molecular targetsSeparation technologiesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 26, 2026
ROR1-PI3K/AKT signaling drives adaptive resistance to cell cycle blockade in TP53 mutated ovarian cancer.

Juuli Raivola, Frida Rantanen, Alice Dini

|Feb 12, 2026
Precision targeting of <i>CCNE1</i>-amplified tumors-lessons from BLU-222 and beyond.

Frida Rantanen, Daniela Ungureanu

|Feb 10, 2026
RIPK3's shape-shifting scaffold: how kinase domain conformation fine-tunes necroptosis.

Daniela Ungureanu

|Nov 06, 2025
Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilities.

Frida Rantanen, Astrid Murumägi, Mariliina Arjama

|Nov 01, 2024
A multiplex single-cell RNA-Seq pharmacotranscriptomics pipeline for drug discovery.

Alice Dini, Harlan Barker, Emilia Piki

|Jul 03, 2023
ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity.

Emilia Piki, Alice Dini, Juuli Raivola

Pageof 2